Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: Analysis of 30 cases

Rheumatology

Volumn 47, Issue 11, 2008, Pages 1686-1691

  Fukaya, S ^a   Yasuda, S ^a   Hashimoto, T ^a   Oku, K ^a   Kataoka, H ^a   Horita, T ^a   Atsumi, T ^a   Koike, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmunity; Haemophagocytic syndrome; Haemophagocytosis; Mortality factors; Systemic lupus erythematosus

Indexed keywords

ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CEFOTIAM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FERRITIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; LIVER ENZYME; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; SULBACTAM; TACROLIMUS; TRIMETHOPRIM; VINCRISTINE; ZONISAMIDE;

ADULT; ADULT ONSET STILL DISEASE; AGED; ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DERMATOMYOSITIS; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG WITHDRAWAL; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LEUKOPENIA; MALE; MONOTHERAPY; MORTALITY; PNEUMOCYSTIS PNEUMONIA; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOPATHY; REMISSION; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEPTICEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOCYTOPENIA; TREATMENT FAILURE; URINARY TRACT INFECTION; VASCULITIS;

ADULT; AGED; AUTOIMMUNE DISEASES; BACTERIAL INFECTIONS; CYCLOPHOSPHAMIDE; CYCLOSPORINE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TACROLIMUS; VIRUS DISEASES; YOUNG ADULT;

EID: 54449101721     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken342     Document Type: Article

References (33)

1. Imashuku S. Differential diagnosis of haemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997;66:135-51.
2. Kumakura S, Ishikura H, Umegae N, Yamagata S, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Am J Med 1997;102:113-5.
3. Dhote R, Simon J, Papo T et al. Reactive hemophagocytic syndrome in adult systemic disease: Report of twenty-six cases and literature review. Arthritis Rheum 2003;49:633-9.
4. Arlet JB, Le TH, Marinho A et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: A report of six patients and a review of the literature. Ann Rheum Dis 2006;65:1596-601.
5. Boelens JJ, Lazo G, Gaiser JF, Wulffraat NM. Epstein-Barr virus-associated haemophagocytic lympho-histiocytosis after stem cell transplantation. Bone Marrow Transplant 2006;38:709-10.
6. Kawabata Y, Hirokawa M, Saitoh Y et al. Late-onset fatal Epstein-Barr virus-associated hemophagocytic syndrome following cord blood cell transplantation for adult acute lymphoblastic leukemia. Int J Hematol 2006;84:445-8.
7. Ostronoff M, Ostronoff F, Coutinho M et al. Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin. Bone Marrow Transplant 2006;37:797-8.
8. Sreedharan A, Bowyer S, Wallace CA et al. Macrophage activation syndrome and other systemic inflammatory conditions after BMT. Bone Marrow Transplant 2006;37:629-34.
9. Masri K, Mahon N, Rosario A et al. Reactive hemophagocytic syndrome associated with disseminated histoplasmosis in a heart transplant recipient. J Heart Lung Transplant 2003;22:487-91.
10. Karasu Z, Kilic M, Cagirgan S et al. Hemophagocytic syndrome after living-related liver transplantation. Transplant Proc 2003;35:1482-4.
11. Karras A, Thervet E, Legendre C. Hemophagocytic syndrome in renal transplant recipients: Report of 17 cases and review of literature. Transplantation 2004;77:238-43.
12. Taniai N, Akimaru K, Kawano Y et al. Hemophagocytic syndrome after living-donor liver transplantation for fulminant liver failure: A case report. Hepatogastroenterology 2005;52:923-6.
13. Wong KF, Hui PK, Chan JK, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med 1991;114:387-90.
14. Lambotte O, Khellaf M, Harmouche H et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine 2006;85:169-82.
15. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
18. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Arthritis Rheum 1980;23:581-90.
19. Yamaguchi M, Ohta A, Tsunematsu T et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
20. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990;33:1065-7.
21. Lightfoot RW Jr, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93.
22. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61:554-8.
23. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 2004;14:205-15.
24. Ljungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. In: Michelson S, Plotkin S, eds. Multidisciplinary approach to understanding cytomegalovirus disease. Amsterdam: Elsevier Science Publishers, 1993;233-7.
25. Iikuni N, Kitahama M, Ohta S, Okamoto H, Kamatani N, Nishinarita M. Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease. Mod Rheumatol 2006;16:282-8.
26. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327-30.
27. Bencivelli W, Vitali C, Isenberg DA et al. Disease activity in systemic lupus erythematosus: Report of the consensus study group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:549-54.
28. Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 1997;89:794-800.
29. Chung TW. CNS involvement in hemophagocytic lymphohistiocytosis: CT and MR findings. Korean J Radiol 2007;8:78-81.
30. Henter JI, Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr 1997;130:358-65.
31. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000;6:601-8.
32. Kaito K, Kobayashi M, Katayama T et al. Prognostic factors of hemophagocytic syndrome in adults: Analysis of 34 cases. Eur J Haematol 1997;59:247-53.
33. Takahashi N, Chubachi A, Kume M et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: The prognostic significance of the underlying diseases. Int J Hematol 2001;74:209-13.